May 12 (Reuters)-
Kidswell Bio Corporation
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2022 Mar 31, 2021 Mar 31, 2023 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 1.57 996 mln
(+57.5 pct) (-7.5 pct)
Operating loss 919 mln loss 969 mln
Recurring loss 952 mln loss 991 mln
Net
Net loss 535 mln loss 1.00
EPS loss 17.35 yen loss 34.79 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - Kidswell Bio Corporation.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4584.T